iConnect R12.3 UAT Dry Run Script 05-1<br>
In this study, the efficacy of botensilimab and balstilimab in mismatch repair deficient (dMMR) and mismatch repair proficient (pMMR) tumors will be assessed.
In this study, the efficacy of botensilimab and balstilimab in mismatch repair deficient (dMMR) and mismatch repair proficient (pMMR) tumors will be assessed.
iConnect R12.3.1 UAT Dry Run for Site Question
Congrats! You have your own personal workspace now.